Circulating IGF-I is associated with fitness and health outcomes in a population of 846 young healthy men

Growth Hormone and IGF Research

Volumn 21, Issue 3, 2011, Pages 124-128

  Nindl, Bradley C ^a   Santtila, Matti ^b   Vaara, Jani ^c,d   Hakkinen, Keijo ^d   Kyrolainen, Heikki ^c,d  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^b Personnel Division of Defence Command   (Finland)

^c NATIONAL DEFENCE UNIVERSITY   (Finland)

^d UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

Biomarker; IGF I; Population based study

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AEROBIC CAPACITY; AGE; ARM STRENGTH; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DRINKING; FAT FREE MASS; FITNESS; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LEG EXTENSION; LEG STRENGTH; LIPOPROTEIN BLOOD LEVEL; MALE; MUSCLE EXERCISE; MUSCULOSKELETAL SYSTEM PARAMETERS; NORMAL HUMAN; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BODY COMPOSITION; BODY MASS INDEX; FINLAND; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE STRENGTH; PHYSICAL FITNESS;

EID: 79958149883     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2011.03.001     Document Type: Article

References (34)

1. Eliakim A., Nemet D., Cooper D.M. Exercise, training, and the GH-IGF-I axis. The Endocrine System in Sports and Exercise 2005, 165-179. Blackwell Publishing, Malden (MA). W.J. Kraemer, A.D. Rogol (Eds.).
2. Frystyk J. Exercise and the growth hormone-insulin-like growth factor axis. Medicine and Science in Sports and Exercise 2010, 42(1):58-66.
3. Nindl B.C., Pierce J.R. Insulin-like growth factor-I as a biomarker of health, fitness, and training status. Medicine and Science in Sports and Exercise 2010, 42(1):39-49.
4. Brugts M.P., van Beld W., Hofland L.J., van der Wansem K., van Koetsveld P.M., Frystyk J., Lambert S.W.J., Janssen J.A.M.J.L. Low circulating insulin-like growth factor-I bioactivity in elderly men is associated with increases mortality. Journal of Clinical Endocrinology and Metabolism 2008, 93:2515-2522.
5. Juls A. Serum levels of insulin-like growth factor-I and its binding proteins in health and disease. Growth Hormone and IGF-I Research 2003, 13:113-170.
6. Barbieri M., Ferrucci L., Ragno E., Corsi A., Bandinelli S., Bonafe M., Olivieri F., Giovagnetti S., Franceschi C., Guralnik J.M., Paolisso G. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Journal of Clinical Endocrinology and Metabolism 2003, 284:E481-E487.
7. Cappola A.R., Bandeen-Roche K., Wind G.S., Volpato S., Fried L.P. Association of IGF-I levels with muscle strength and mobility in older women. Journal of Clinical Endocrinology and Metabolism 2001, 86(9):4139-4146.
8. Eliakim A., Scheett T.P., Newcomb R., Mohan S., Cooper D.M. Fitness, training, and the growth hormone/insulin-like growth factor-I axis in prepubertal girls. J. Clin. Endo. Metab. 2001, 86:2797-2802.
9. Kiel D.P., Puhl J., Rosen C.J., Berg K., Murphy J.B., MacLean D.B. Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations. Journal of the American Geriatric Society 1998, 46(7):823-828.
10. Nindl B.C., Scoville C.R., Sheehan K.M., Leone C.D., Mello R.P. Gender differences in regional body composition and somatotrophic influences of IGF-I and leptin. Journal of Applied Physiology 2002, 92:1611-1618.
11. Ceda G.P., Dall'Aglio E., Magnavallo A., Vargas N., Fontana V., Maggio M., Valenti G., Lee P.D.K., Hintz R.L., Hoffman A.R. The insulin-like growth factor axis and plasma lipid levels in the elderly. Journal of Clinical Endocrinology and Metabolism 1998, 83:499-502.
12. Karl J.P., Alemany J.A., Koenig C., Kraemer W.J., Frystyk J., Young A.J., Nindl B.C. Diet, Body Composition, and Physical Fitness Influences on IGF-I Bioactivity in Women. Growth Hormone and IGF-I Research 2009, vol. 19467892. PMID.
13. Gibson A.L., Holmes J.C., Desautels R.L., Edmonds L.B., Nuudi L. Ability of a new octaopolar bioimpedance spectroscopy analyzers to predict 4-component-model percentage body fat in Hispanic, black, and white adults. American Journal of Clinical Nutrition 2008, 87:332-338.
14. Fogelholm M., Malmberg J., Suni J., Santtila M., Kyrolainen H., Mantysaari M., Oja P. International physical activity questionnaire: validity against fitness. Medicine and Science in Sports and Exercise 2006, 38(4):753-760.
15. Landin-Wilheimsen K., Wilheimsen L., Lappas G., Rosen T., Lindstedt G., Lundberg P., Bengtsson B. Serum insulin-like growth factor-I in a random population sample of men and women: relation of age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology 1994, 41:351-357.
16. Nindl B.C., Alemany J.A., Kellogg M.D., Rood J., Allison S.A., Young A.J., Montain S.J. Utility of circulating IGF-I as a biomarker for assessing body composition changes in men during periods of high physical activity superimposed upon energy and sleep restriction. Journal of Applied Physiology 2007, 103(1):340-346.
17. Rosendahl L., Langberg H., Flyvberg A., Frystyk J., Orskov H., Kjaer M. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. Journal of Applied Physiology 2002, 93:1669-1675.
18. Nindl B.C., Pierce J.R., Durkot M.J., Tuckow A.P., Kennett M.J., Nieves J.W., Cosman F., et al. Relationship between growth hormone in vivo bioactivity, the insulin-like growth factor-I system and bone mineral density in young, physically fit men and women. Growth Horm IGF Res. 2008, 18(5):439-445.
19. Baumgartner R.M., Waters D.L., Gallagher D., Morley J.E., Garry P.J. Predictors of skeletal muscle mass in elderly men and women. Mechanisms of Ageing and Development 1999, 107:123-136.
20. Colbert L.H., Rosen C.J., Goodpaster B.H., Newman A.B., Kritchevsky S.B., Satterfield S., Kanaya A.M., Taffe D.R., Harris T.B. Insulin-like growth factor-I. Journal of the American Geriatric Society 2004, 52(11):1962-1963.
21. Gomez J.M., Maravall F.J., Gomez N., Navarro M.A., Casamitjana R., Soler J. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin. Endocrinol. (Oxf) 2003, 58(2):213-219.
22. Jakobsdottir, I.C. van Nieuwpoort, L. Schaap, N.M. van Schoor, P. Lips, and M.L. Dent. Serum insulin-like growth factor-I and body composition in community dwelling older people, Clinical Endocrinology 73 (2) (2010) 173-180.
23. Ceda G.P., Dall'Aglio E., Maggio M., Lauretani F., Bandinelli S., Falzoi C., Grimaldi W., Ceresini G., Corradi F., Ferrucci L., Valenti G., Hoffman A.R. Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J. Endocrinol. Invest. 2005, 28(11 Suppl Proc):96-100.
24. O'Conner K.G., Smith J.D., Harman M., Plato C.C., Roy T.A., Sherman S.S., Blackman M.R. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy men and women. Journal of Gerontology 1998, 53A(3):M176-M182.
25. Juul A., Scheike M., Davidsen M., et al. Low serum insulin-like growth factor-I is associated with increased risk of ischemic heart disease: a population-based case control study. Circulation 2002, 106:939-944.
26. Vasan R.S., Sullivan L.M., D'Agostino R.B., Roubenoff R., Harris T., Sawyer D.B., Levy D., Wilson P.W. Serum insulin-like growth factor-I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann. Intern. Med. 2003, 139:642-648.
27. Eliakim A., Brasel J.A., Mohan S., Wong W.L.T., Cooper D.M. Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am. J. Physiol: Reg. Integ. Comp. 1998, 44:R308-R314.
28. Glaser S., Friedrich N., Ewert R., Schaper C., Nauck M., Dorr M., Volzke H., Felix S.B., Krebs A., Wallaschofski H., Koch B. Association between serum insulin-like growth factor (IGF)-I and IGF binding protein-3 and lung function. Journal of Clinical Endocrinology and Metabolism 2009, 94:2452-2458.
29. Vitale G., Galderisi M., Colao A., Innelli P., Guerra G., Guerra E., Dini F.L., Orio F., Soscia A., De Divitiis U., Lombardi G. Circulating IGF-I levels are associated with increases biventricular contractility in top-level rowers. Clinical Endocrinology 2008, 69:231-236.
30. Delafontaine P., Song Y., Li Y. Expression, regulation, and function of IGF-I, IGF-IR, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 2004, 24:435-444.
31. Schini-Kerth V.V. Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. Journal of Endocrinological Investigation 1999, 22:82-88.
32. Schini-Kerth V.V. Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. Journal of Endocrinological Investigation 1999, 22:82-88.
33. Kostka T., Arsac L.M., Patricot M.C., Berthouze S.E., Lacour J., Bonnefoy M. Leg extensor power and dehydroepiandrosterone sulfate, insulin-like growth factor-I and testosterone in healthy active elderly people. European Journal of Applied Physiology 2000, 82:83-90.
34. Papadakis M.A., Grady D., Tierney M.J., Black D., Wells L., Grunfeld C. Insulin-like growth factor-I and functional status in healthy older men. Journal of the American Geriatric Society 1995, 43(12):1350-1355.